Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial)
Clinical trial NCT03674424 · COMPLETED
Trial details
- NCT number
- NCT03674424
- Sponsor
- Jules Bordet Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2021-12-07
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.